The hallmarks of aging · Where the damage starts

Epigenetic drift

Scientific name: Epigenetic alterations

Every cell carries the same DNA. Chemical tags on the DNA and on its packaging decide which genes each cell uses. With age these tags drift: genes that should stay off switch on, others go quiet, and cells do their jobs less well.

Measurable today: biological-age tests are sold, but what a change in the score means is still unproven.

Why it matters

Why it matters to you

The tags decide what each cell is.

A skin cell and a brain cell carry the same DNA. The tags are what make them different. As the tags drift, cells slowly lose some of that identity and work less well.

It is what biological-age tests read.

The tag pattern in blood changes so steadily with age that it can estimate how old someone is. These estimates, called epigenetic clocks, are the biological-age tests sold today.

Unlike mutations, tags can be reset.

In mice, briefly switching on three genes normally active in early development restored a younger tag pattern in nerve cells of the eye and brought back lost vision. It is one of the most watched ideas in aging research, and still far from a treatment.

Source: PubMed 33268865

Measurement

Can it be measured?

Epigenetic clock test (biological age)

Sold to consumers

What it showsAn estimate of your biological age, or of how fast you are aging, read from the tags at hundreds of spots on the DNA in a blood or saliva sample.

LimitsDifferent clocks measure different things and can disagree. Across 51 human intervention studies, clocks built to predict death risk or pace of aging responded most consistently, but no clock has been proven to show that a change means a longer or healthier life.

Sources: PubMed 42629466

Tag patterns in other tissues

Research only

What it showsHow the tags change with age in muscle, brain, liver, and other organs. A pooled analysis of more than 15,000 samples from 17 tissues found some changes shared across the body and some specific to each tissue.

LimitsMost tests use blood, which mainly reflects immune cells. A blood result may not describe your brain, muscle, or liver.

Sources: PubMed 42362890

DNA packaging and gene-switch lab methods

Research only

What it showsHow tightly DNA is packed, which genes are open for use, and how the DNA folds in 3D, measured in tissue or single cells.

LimitsThese need tissue samples and specialized labs. There are no normal ranges for one person.

A biological-age result is a statistical estimate from tag patterns. It is not a measurement of how long you will live.

What would make it measurable

  • Clocks proven in trials to predict real health outcomes, so a change in the score can be trusted.
  • Agreed standards, so the same sample gives the same answer from any company.
  • Affordable tests for tissues other than blood.
What can be done

What can be done about it?

Eight items in our catalog have human studies that support an effect on these tags, most of them by supplying the raw materials or helpers cells use to add and remove tags, such as folate, vitamin B12, and vitamin C. That is not the same as slowing aging, which no product has been shown to do, and a better clock score alone is not proof that it has.

Three examples from our catalog, rotated daily: one with stronger evidence here, one with early evidence, and one where we found none. A sample, not a ranking or a recommendation. Ratings as of October 25, 2026. What the evidence levels mean.

Metabolites & Cofactors

NMN

Evidence for epigenetic drift: Supported

Human studies support it engaging this aging driver, short of the strongest trial designs.

Vitamins & Minerals

Vitamin D3

Evidence for epigenetic drift: Emerging

Only early or animal-stage evidence for this aging driver so far.

Vitamins & Minerals

Boron

Evidence for epigenetic drift: None found

We did not find qualifying evidence that it engages this aging driver.

We have not found strong evidence for it in any aging driver yet.

See the full picture for your own routine

The Longevity Intelligence Report shows how what you take and do covers epigenetic drift and the other hallmarks. Members also see every item in our catalog ranked by the strength of its evidence for epigenetic drift. Opens in December.

Get early access
New research

New studies on epigenetic drift

Picked for what they add to the biology, and to the chance of one day treating it, in plain words. Research checked October 17, 2026.

Epigenetic drift

Which aging clocks actually move when people change something

People, 51 intervention studies pooled · Nature Medicine · August 21, 2026

What they foundResearchers ran 16 well-known epigenetic aging clocks on data from 51 human intervention studies. Clocks built to predict death risk or the pace of aging responded most consistently.

What it does not showA clock moving is not proof that anyone will live longer. These clocks are still being tested as stand-ins for real health outcomes.

Why it mattersClock tests are sold to consumers today. This helps show which clocks can tell whether an intervention is working.

Read the study on PubMed ↗
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans.
Epigenetic drift

Insomnia therapy slowed a pace-of-aging score in older adults

People, 92 adults aged 60 and over with insomnia, followed 2 to 3 years · Lancet Healthy Longevity · August 12, 2026

What they foundOlder adults with insomnia got either cognitive behavioural therapy for insomnia, a structured non-drug treatment, or sleep education. Two to three years later, the therapy group showed a slightly slower pace of aging on one clock. Two other clocks did not change significantly.

What it does not showA follow-up analysis of 92 people. A slower clock pace is not proof of a longer or healthier life.

Why it mattersIt is a randomized test of a non-drug treatment against an active comparison, and it shows clocks can disagree about the same change.

Read the study on PubMed ↗
Cognitive behavioural therapy for insomnia and epigenetic ageing: secondary analysis from a randomised controlled trial.
Epigenetic drift

In the aging human memory center, the 3D folding of DNA erodes

People, donated brain tissue spanning the adult lifespan · Science · July 23, 2026

What they foundResearchers mapped gene activity, tags, and DNA folding in the hippocampus, the brain's memory center. With age, the 3D folding of DNA eroded in every cell type, and between 50 and 75 the brain's original immune cells were largely replaced.

What it does not showTissue from donors at one point in time. It does not show what causes the erosion or whether it can be slowed.

Why it mattersIt shows the drift is not only in blood, where clocks measure it, but in the brain region most tied to memory.

Read the study on PubMed ↗
Epigenetic and 3D genome reprogramming during the aging of the human hippocampus.

Follow the research on epigenetic drift

Pick the ones you want to follow. Starting in December, we'll email you every two weeks when new studies or new tests come out on them. Longevity Intelligence Report members also get the plain-English read on each one: why it matters, and whether it should change what you're doing.

Free, no account needed. We keep your email and the topics you pick, nothing else. Unsubscribe anytime.

From the articles

Articles on epigenetic drift

Go deeper

Connected hallmarks

How the biology works

DNA methylation is the best-studied tag. A methyl group is a small chemical cap (one carbon with three hydrogens) clipped onto the DNA, almost always at a spot called a CpG site, which is just a cytosine letter (C) sitting next to a guanine letter (G) along the strand. When these caps cluster on a gene's control region they usually turn that gene down or off. With age the pattern drifts in a characteristic way: regions that are normally heavily capped lose caps, and some regions that are normally bare gain them, so the cell's careful on/off map of its genes gradually smears. This drift is so reproducible that it is exactly what the methylation clocks read.

Histones are the second layer. DNA does not float loose; it is wound around spool-shaped proteins called histones, and the tails of those spools carry their own chemical tags (acetyl groups that loosen the wrapping and open genes, methyl groups that can open or close them depending on where they land). With age these histone marks are lost and redistributed, so the packaging that should keep certain genes tightly wound and silent loosens, and genes that should be active get locked away. The cell's filing system slowly disorganizes.

Heterochromatin loss is a specific and important version of this. Heterochromatin is the densely packed, switched-off portion of the genome, the part kept tightly coiled so it stays quiet, including ancient parasitic DNA elements that are supposed to remain silenced. With age this dense packing erodes (the field calls the broad phenomenon epigenetic drift), silenced regions wake up, and previously parked genetic elements can start firing, adding noise and inflammation.

Chromatin remodeling machinery, the molecular machines that physically slide and reposition histones to open or close stretches of the genome, also loses precision with age. The result is that access to genes is granted and denied in the wrong places, which is the mechanical side of the same identity-blurring story.

Net effect: loss of cellular identity. Add up drifting DNA caps, scrambled histone marks, eroding heterochromatin, and sloppy remodeling, and cells partly forget the tightly controlled gene program that made them a specific cell type. They tilt toward inflammatory and stress gene programs and away from their specialized jobs. This is the cell-level meaning of epigenetic aging.

The information theory of aging and partial reprogramming. One influential idea frames aging here as a loss of information: the DNA hardware (the letters) stays largely intact, but the epigenetic software (which genes are on or off) gets corrupted over time, like scratches accumulating on a disc whose underlying data is still there. The provocative follow-on is partial reprogramming: briefly exposing cells to a subset of the Yamanaka factors (OSK, three of the four master genes Shinya Yamanaka used to rewind adult cells all the way back to a stem-cell state) appears to roll the epigenetic settings back toward a younger pattern without fully erasing the cell's identity. In dishes and some animal tissues this has restored youthful gene-expression patterns, which is why this hallmark draws enormous interest, but the same approach pushed too hard turns cells into tumors, so the entire challenge is doing a little of it safely.

Where treatment research is heading
Next few years

Better, standardized clocks and clock-readout intervention studies (DunedinPACE, GrimAge2)

Second-generation clocks like GrimAge2 and the pace-of-aging metric DunedinPACE predict disease and mortality better than the first-generation Horvath and Hannum clocks, and a growing wave of trials now uses a clock as the readout to test whether interventions move biological age, which could finally turn the clocks into usable outcome measures.

Not ready yet: Test-retest noise means one person's number can swing between blood draws without anything real changing, the clocks are tissue- and method-dependent, and almost none are yet validated to confirm that a given intervention truly reset biology rather than just nudging a correlated marker.

Further out

Targeted epigenetic editing to rewrite specific tags

Tools derived from CRISPR can now steer methylation-adding or methylation-removing machinery to a chosen gene, in principle letting researchers correct a single drifted setting (turn a wrongly silenced gene back on, or quiet a wrongly active one) without touching the DNA sequence at all.

Not ready yet: Knowing which of millions of tags to edit, delivering the editors into the right cells across a whole body, and avoiding off-target changes are all unsolved, so this is a precise lab tool rather than a therapy today.

Sirtuin and NAD-axis approaches to support epigenetic maintenance

Sirtuins are histone deacetylases that help keep genes correctly silenced, and they depend on NAD, a coenzyme that falls with age. Compounds aimed at raising NAD, including nicotinamide riboside and NMN, plus sirtuin-activator research, aim to keep this epigenetic-maintenance crew better staffed and slow the drift.

Not ready yet: Human evidence that raising NAD actually slows epigenetic aging or improves outcomes is early and inconsistent, sirtuin biology is more tangled than early excitement suggested, and a marker change is not a proven health benefit.

Long shots

Safe partial cellular reprogramming to reset the epigenome (OSK in vivo)

The boldest vision in aging biology is partial reprogramming: delivering a brief, tightly controlled pulse of the Yamanaka factors Oct4, Sox2, and Klf4 (OSK) inside living tissue to roll the epigenetic settings back toward a youthful state without erasing what each cell is. In animals this has restored vision in damaged optic nerves and reversed some aging features, and companies including Altos Labs and Retro Biosciences are pursuing it, which is the proof of concept driving the whole field.

Not ready yet: Pushed too far the same factors strip cell identity and cause cancer, so the entire problem is doing just enough and stopping in time. We do not yet know the youthful target setting for each tissue, how to deliver and dose the pulse safely across a whole body, or how to guarantee cells regain their exact identity without tipping toward tumors, so this remains a high-risk, far-horizon goal.

Facts and sources on this page checked October 17, 2026. This page explains research. It is not medical advice or a recommendation to take anything. How we grade the evidence.